Answers are grounded in this paper and cite their sources.
Repetitive transcranial magnetic stimulation (rTMS) represents a promising therapeutic option for Alzheimer's Disease (AD) treatment. Standard rTMS protocols typically involve prolonged treatment schedules that may hinder patient adherence, particularly in frail individuals. Here, we evaluated the safety and efficacy of an accelerated intermittent Theta Burst Stimulation (aiTBS) protocol in a randomized, double-blind, sham-controlled, crossover, proof-of-concept study involving thirteen patients with a clinical diagnosis of AD. Participants received real and sham stimulation over the left dorsolateral prefrontal cortex (DLPFC) or left precuneus. Real aiTBS significantly improved global cognition, as measured by the ADAS-Cog, with a net improvement of approximately 3.3 points relative to sham. No serious adverse events were reported. Although no significant difference was found between cortical targets, a trend favored the DLPFC. These preliminary findings suggest that aiTBS is a feasible, well-tolerated, and effective intervention for rapidly enhancing cognitive function in AD, supporting the need for larger confirmatory investigations.
No takes yet. Share an insight, caveat, or question.
Falato et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: